Interleukin 33 Promotes Liver Sinusoidal Endothelial Cell Dysfunction and Hepatic Fibrosis in Diabetic Mice
IL33 drives LSEC dysfunction and promotes diabetic hepatic fibrosis, thus a potential therapeutic target for diabetic liver fibrosis.
Authors
- Ping Yao (ORCID: https://orcid.org/0000-0002-0192-9546)
- Chanhua Liang
- Bangfu Wu
- Xueer Cheng
- Baohua Xu
- Huimin Chen (ORCID: https://orcid.org/0000-0002-4643-1661)
- Xingzhu Yin
- Chao Gao (ORCID: https://orcid.org/0000-0002-4019-2743)
- Yanyan Li (ORCID: https://orcid.org/0000-0001-5541-6888)
- Mo Li (ORCID: https://orcid.org/0000-0003-2772-5848)
- Li Chen (ORCID: https://orcid.org/0009-0007-6683-0102)
- Dongyan Li (ORCID: https://orcid.org/0000-0003-2337-4163)
- Yuhan Tang (ORCID: https://orcid.org/0000-0003-1290-2039)
- Ying Zhao (ORCID: https://orcid.org/0000-0001-8675-6463)
Institutions
- Chinese Center For Disease Control and Prevention (CN)
- Chinese Academy of Sciences (CN)
- Wuhan Institute of Virology (CN)
- Tongji Hospital (CN)
- Shenzhen Nanshan Center for Chronic Disease Control (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Diabetes & Metabolism Journal
- Published
- 2025-05-22
- DOI
- https://doi.org/10.4093/dmj.2024.0532
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Natural Science Foundation of China
- Huazhong University of Science and Technology
- Tongji University